K223705 is an FDA 510(k) clearance for the EndoflipTM 300, a System, Gastrointestinal Motility (electrical) (Class II — Special Controls, product code FFX), submitted by Covidien, LLC (Santa Clara, US). The FDA issued a Cleared decision on April 14, 2023, 123 days after receiving the submission on December 12, 2022. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.1725.
| 510(k) Number | K223705 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 12, 2022 |
| Decision Date | April 14, 2023 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | FFX — System, Gastrointestinal Motility (electrical) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.1725 |